Moxonidine is a new-generation centrally acting antihypertensive drug, which is approved for the treatment of mild to moderate essential hypertension. moxonidine has been shown to present blood pressure-independent beneficial effects on insulin resistance syndrome. Reference standards of Moxonidine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Moxonidine - Impurity B [catalogue_number] => PA 13 56020 [category_ids] => ,79,80,71,78,70,82, [chemical_name] => [weight] => 237.26 [form] => C10H15N5O2 [cas] => 75439-01-9 [pslug] => 75439-01-9-moxonidine-impurity-b-pa1356020 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 13 56020
CAS :
Molecular Formula : C10H15N5O2
Molecular Weight : 237.26
stdClass Object ( [pname] => Moxonidine - Impurity C [catalogue_number] => PA 13 56030 [category_ids] => ,79,80,71,78,70,82, [chemical_name] => [weight] => 223.23 [form] => C9H13N5O2 [cas] => 352457-34-2 [pslug] => 352457-34-2-moxonidine-impurity-c-pa1356030 [latest_product] => 0 [linkproducts] => 1 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 13 56030
Molecular Formula : C9H13N5O2
Molecular Weight : 223.23
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
